Barcelona-Clinic Liver-Cancer
Subjects and methods: Retrospective study on 31 patients diagnosed with hepatocellular carcinoma, stage Barcelona-Clinic Liver-Cancer (BCLC) B was unsuitable or failed after local interventions, BCLC C, treated systemic therapy with Bevacizumab combined with Atezolizumab regimen at K Hospital, from May 2020 to March 2023.
Subjects and methods : Retrospective study on 31 patients diagnosed with hepatocellular carcinoma, stage Barcelona-Clinic Liver-Cancer ( BCLC ) B was unsuitable or failed after local interventions, BCLC C, treated systemic therapy with Bevacizumab combined with Atezolizumab regimen at K Hospital, from May 2020 to March 2023 .